Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherko Kuemmel

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Anticancer Research|April 19, 2006
Actinomycotic inflammatory disease and misdiagnosis of ovarian cancer. A case reportJalid Sehouli, Jens H Stupin, Ulrike Schlieper, et al.
Anticancer Research|January 5, 2007
Epidermal growth factor receptor changes during breast cancer metastasisIlka B Fuchs, Ildiko Siemer, Helmut Bühler, et al.
BMC Cancer|November 23, 2012
Integrative oncology for breast cancer patients: introduction of an expert-based modelGustav J Dobos, Petra Voiss, Ilka Schwidde, et al.
NPJ Breast Cancer|July 31, 2020
Olaparib for metastatic breast cancer in a patient with a germline <i>PALB2</i> variantSherko Kuemmel, Hakima Harrach, Rita K Schmutzler, et al.
Orphanet Journal of Rare Diseases|August 17, 2021
Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancersMattea Reinisch, Sherko Kuemmel, Elisabeth Breit, et al.
Therapeutic Advances in Medical Oncology|October 4, 2023
Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in GermanyMattea Reinisch, Simona Bruzas, Jennifer Spoenlein, et al.
Cancers|September 28, 2021
Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical PracticeSimona Bruzas, Sherko Kuemmel, Hakima Harrach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2010
Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer stagingTill-Alexander Heusner, Sherko Kuemmel, Angela Koeninger, et al.
Cancer Management and Research|August 27, 2021
Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer: A Systematic Literature ReviewGebra Cuyún Carter, Maitreyee Mohanty, Keri Stenger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2008
Breast cancer staging in a single session: whole-body PET/CT mammographyTill A Heusner, Sherko Kuemmel, Lale Umutlu, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Anticancer Research|April 19, 2006
Actinomycotic inflammatory disease and misdiagnosis of ovarian cancer. A case reportJalid Sehouli, Jens H Stupin, Ulrike Schlieper, et al.
Anticancer Research|January 5, 2007
Epidermal growth factor receptor changes during breast cancer metastasisIlka B Fuchs, Ildiko Siemer, Helmut Bühler, et al.
BMC Cancer|November 23, 2012
Integrative oncology for breast cancer patients: introduction of an expert-based modelGustav J Dobos, Petra Voiss, Ilka Schwidde, et al.
NPJ Breast Cancer|July 31, 2020
Olaparib for metastatic breast cancer in a patient with a germline <i>PALB2</i> variantSherko Kuemmel, Hakima Harrach, Rita K Schmutzler, et al.
Orphanet Journal of Rare Diseases|August 17, 2021
Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancersMattea Reinisch, Sherko Kuemmel, Elisabeth Breit, et al.
Therapeutic Advances in Medical Oncology|October 4, 2023
Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in GermanyMattea Reinisch, Simona Bruzas, Jennifer Spoenlein, et al.
Cancers|September 28, 2021
Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical PracticeSimona Bruzas, Sherko Kuemmel, Hakima Harrach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2010
Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer stagingTill-Alexander Heusner, Sherko Kuemmel, Angela Koeninger, et al.
Cancer Management and Research|August 27, 2021
Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer: A Systematic Literature ReviewGebra Cuyún Carter, Maitreyee Mohanty, Keri Stenger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2008
Breast cancer staging in a single session: whole-body PET/CT mammographyTill A Heusner, Sherko Kuemmel, Lale Umutlu, et al.
Pageof 9